HemoShear Therapeutics, LLC, a privately held biotechnology company, today announced an extension of its partnership with Takeda Pharmaceutical Company Limited to discover and develop additional novel therapeutics for liver diseases, including nonalcoholic steatohepatitis (NASH).
{iframe}https://www.prnewswire.com/news-releases/takeda-and-hemoshear-therapeutics-extend-exclusive-drug-discovery-partnership-in-liver-diseases-300815262.html{/iframe}